Silence Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $224 | $142 | $24,327 | $1,142 |
Gross Profit | 139 | 88 | 22,721 | -1,632 |
EBITDA | -22,491 | -19,809 | 7,192 | -21,441 |
EBIT | -22,639 | -19,916 | 7,073 | -21,556 |
Net Income | -27,354 | -28,530 | 14,174 | -27,012 |
Net Change In Cash | 224 | 142 | 24,327 | 1,142 |
Free Cash Flow | -21,832 | -12,313 | -24,920 | -19,705 |
Cash | 41,739 | 64,886 | 121,330 | 61,953 |
Basic Shares | 47,232 | 47,226 | 47,224 | 46,736 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43,258 | $25,375 | $17,501 | $12,415 |
Gross Profit | 31,448 | 15,057 | 6,621 | 4,959 |
EBITDA | -48,989 | -49,778 | -47,885 | -45,421 |
EBIT | -49,582 | -50,276 | -48,367 | -45,848 |
Net Income | -45,309 | -43,267 | -40,489 | -39,410 |
Net Change In Cash | 43,258 | 25,375 | 17,501 | 12,415 |
Free Cash Flow | -67,851 | -39,395 | -45,896 | 5,472 |
Cash | 121,330 | 54,031 | 54,816 | 73,537 |
Basic Shares | 47,224 | 37,092 | 32,194 | 29,650 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.55 |
2025-03-31 | -$0.60 |
2024-12-31 | $0.17 |
